BIOFLOW III Satellite-Italy Orsiro Stent System

NCT02028728 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 609

Last updated 2017-10-02

No results posted yet for this study

Summary

Clinical evaluation of the Orsiro LESS in subjects requiring coronary revascularization with Drug Eluting Stents (DES). 500 subjects will be enrolled in this registry. The sample size maybe increased in order to reach the subgroup sizes (Diabetes, small vessel, AMI and CTO).

Conditions

  • Coronary Artery Diseases

Sponsors & Collaborators

  • Biotronik Italia S.p.A.

    lead INDUSTRY

Principal Investigators

  • Martina Del Maestro · BIOTRONIK ITALIA SPA

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02028728 on ClinicalTrials.gov